Pharmaceutical Research and Manufacturers of America v. McClain
Certiorari Denied
Petition for certiorari denied on December 9, 2024.
Issue
Whether the U.S. Court of Appeals for the 8th Circuit erred in holding that a state may strip manufacturers of the ability preserved to them by the federal 340B Drug Pricing Program to impose conditions on the use of contract pharmacies as part of the offer to provide 340B-priced drugs and intrude on 340B"s centralized enforcement scheme.
Jul 31, 2024Petition for a writ of certiorari filed. (Response due September 3, 2024)Aug 20, 2024Motion to extend the time to file a response from September 3, 2024 to November 4, 2024, submitted to The Clerk.
Aug 21, 2024Motion to extend the time to file a response is granted and the time is extended to and including November 4, 2024.
Sep 3, 2024Brief amicus curiae of Kalderos, Inc. filed.Nov 4, 2024Brief of respondents Community Health Centers of Arkansas and Piggott Community Hospital in opposition filed.Nov 4, 2024Brief of respondent Alan McClain, Commissioner of the Arkansas Insurance Department, in opposition filed.Nov 19, 2024DISTRIBUTED for Conference of 12/6/2024.
Nov 19, 2024Reply of petitioner Pharmaceutical Research and Manufacturers of America filed. (Distributed)Dec 9, 2024Petition DENIED.
Recommended Citation: Pharmaceutical Research and Manufacturers of America v. McClain, SCOTUSblog, https://www.scotusblog.com/cases/pharmaceutical-research-and-manufacturers-of-america-v-mcclain/